RAC1 and cancer: In order to verify that the investigated effects of resveratrol on the growth of CAL-27 cells were associated with RAC1 inhibition, cancer cells were treated with RAC1 inhibitor (NSC23766) and agonist (DAM) for 4 h and then incubated with 20 μΜ resveratrol for 48 h.